腹腔镜结直肠癌肝转移一期切除术的临床疗效

Clinical effect of laparoscopic Ⅰ-stage resection for colorectal liver metastasis

  • 摘要: 目的:探讨腹腔镜结直肠癌肝转移一期切除术的安全性、可行性及临床疗效。
    方法:采用回顾性队列研究方法。收集2012年2月至2015年10月郑州大学附属肿瘤医院收治的11例行腹腔镜结直肠癌肝转移一期切除术患者的临床病理资料。结直肠癌原发灶术前均经肠镜、腹部CT及病理学活组织检查确诊,肝转移灶术前经腹部增强CT或MRI检查诊断。术前依据患者情况施行个体化辅助治疗。患者行腹腔镜结直肠癌肝转移一期切除术。患者术后接受FOLFOX6(奥沙利铂+亚叶酸钙+氟尿嘧啶)或FOLFRIRI(伊立替康+亚叶酸钙+氟尿嘧啶)方案辅助化疗。记录患者(1)术前检查指标:肿瘤位置、肿瘤直径、术前治疗情况。(2)术中情况:手术方式、术中出血量、手术时间、切缘情况、淋巴结清扫数目。(3)术后情况:并发症、病理学检查结果、术后胃肠道功能恢复时间、进食时间、术后住院时间、术后辅助治疗情况和肿瘤复发情况。采用门诊和电话方式随访。患者定期复查肿瘤标志物、超声、腹部CT监测肿瘤复发情况,随访时间截至2015年11月。正态分布的计量资料采用±s表示,偏态分布的计量资料采用M(范围)表示。
    结果:(1)术前检查指标:升结肠癌2例、降结肠癌1例、乙状结肠癌2例、直肠癌6例。肝脏单发转移灶6例,肿瘤直径 2.0~5.0 cm;肝脏多发转移灶5例,平均2.4枚/例,肿瘤直径1.0~4.0 cm。4例患者术前行新辅助化疗, 1例直肠癌患者术前行新辅助放疗。(2)术中情况:11例患者均成功行腹腔镜结直肠癌肝转移一期切除术,其中行腹腔镜肝脏不规则楔形切除术7例、规则性肝段(叶)切除术4例;左半结肠切除术2例、右半结肠切除术2例、Miles术4例、Dixon术3例。患者手术时间为(245±61)min,术中出血量为(400±277)mL,术中未发生不可控制的出血。结直肠癌标本远、近端切缘均为阴性(R0切除),直肠癌标本的环周切缘亦为阴性。中位淋巴结清扫数目16枚(11~27枚),中位阳性淋巴结0枚(0~7枚)。肝脏肿瘤切缘阴性10例(R0切除),镜下切缘阳性1例(R1切除)。(3)术后情况: 2例患者发生并发症,其中腹腔积液1例、腹腔感染1例,无胆汁漏、腹腔出血、吻合口漏、膈下脓肿、肝衰竭等严重并发症发生。术后胃肠道恢复时间为(3.0±0.6)d,进食时间为(3.0±0.9)d,术后住院时间为(11.0±4.0)d。11例患者术后均行FOLFOX6方案辅助化疗,其中1例因再发肝转移癌更换为FOLFRIRI方案化疗。11例患者均获得随访,中位随访时间为17个月(2~44个月),随访期间1例患者因肺、脑和腹腔转移死亡;10例生存,其中1例患者再发肝转移癌,其余患者未见肿瘤复发。
    结论:选择合适的患者行腹腔镜结直肠癌肝转移一期切除术安全、可行,患者近期疗效满意。

     

    Abstract: Objective:To investigate the safety, feasibility and clinical effect of laparoscopic Ⅰstage resection of colorectal liver metastasis (CRLM).
    Methods:The retrospective cohort study was adopted. The clinicopathological data of 11 patients who underwent laparoscopic Ⅰstage resection of CRLM at the Affiliated Tumor Hospital of Zhengzhou University from February 2012 to October 2015 were collected. The primary lesions were confirmed by preoperative colonoscopy, abdominal CT and pathological biopsy, and liver metastases were diagnosed by abdominal enhanced CT or MRI. Patients selected preoperative individualized adjuvant therapy according to their conditions, and then underwent laparoscopic Ⅰstage resection of CRLM. After operation, patients received adjuvant chemotherapy of FOLFOX6 (oxaliplatin+calcium folinate+fluorouracil) or FOLFRIRI (irinotecan+calcium folinate+fluorouracil) regimens. The pre, intra and postoperative indexes were recorded, including (1) location and diameter of tumor and preoperative treatment; (2) surgical method, volume of intraoperative blood loss, operation time, resection margin and number of lymph node dissected; (3) complications, result of pathological examination, time of gastrointestinal function recovery, time for diet intake, duration of hospital stay, adjuvant therapy and recurrence of tumor. Patients were followed up by outpatient examination and telephone interview. The regular reexaminations of tumor marker, ultrasound and abdominal CT were applied to patients for detecting the recurrence of tumor till November 2015. Measurement data with normal distribution and with skewed distribution were presented as ±s and M(range), respectively.
    Results:(1)Preoperative indexes: ascending colon cancer was detected in 2 patients, descending colon cancer in 1 patient, sigmoid cancer in 2 patients and rectal cancer in 6 patients. There were 6 solitary liver metastases with tumor diameter of 2.0-5.0 cm and 5 multiple liver metastases with average tumor number of 2.4 and tumor diameter of 1.0-4.0 cm. Four patients underwent preoperative neoadjuvant chemotherapy and 1 with rectal cancer underwent neoadjuvant radiotherapy. (2) Intraoperative status: all the 11 patients received successful laparoscopic Ⅰstage resection of CRLM. Laparoscopic liver irregular wedge resection was performed in 7 patients, regular hepatic lobes resection in 4 patients, left hemicolectomy in 2 patients, right hemicolectomy in 2 patients, Miles operation in 4 patients and Dixon operation in 3 patients. The operation time and volume of intraoperative blood loss were (245±61)minutes and (400±277)mL, without the occurrence of uncontrollable bleeding. The distal and proximal resection margins of colorectal cancer specimens (R0 resection) and circumferential resection margin of rectal cancer were negative. The median number of lymph node dissected, positive lymph node, negative resection margin of liver tumor (R0 resection)and positive laparoscopic resection margin (R1 resection) were 16 (range, 11-27), 0 (range, 0-7), 10 and 1, respectively. (3) Postoperative status: 2 patients had postoperative complications including 1 with intra peritoneal effusion and 1 with intraperitoneal infection, without occurrence of bile leakage, abdominal bleeding, anastomotic leakage, subphrenic abscess and hepatic failure. The time of postoperative gastrointestinal function recovery, time for diet intake and duration of hospital stay were (3.0±0.6)days, (3.0±0.9)days and (11.0±4.0)days, respectively. All the 11 patients underwent adjuvant chemotherapy of FOLFOX6 regimen, and 1 of 11 patients changed FOLFOX6 regimen into FOLFRIRI regimen due to recurrence of liver metastases. All the patients were followed up for a median time of 17 months (range, 2-44 months). During the followup, 1 patient died of pulmonary, brain and abdominal metastases and 10 patients had survival without recurrence of tumor except 1 with recurrence of liver metastasis.
    Conclusion Laparoscopic Ⅰstage resection of CRLM is safe and feasible for eligible patients, with a satisfactory shortterm outcome.

     

/

返回文章
返回